D-0154-2020 Class III Terminated

Recalled by Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center — West Columbia, SC

FDA drug recall D-0154-2020 was initiated by Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center on Oct 21, 2019 and is designated Class III. Reason for recall: Incorrect labeling: Incorrect or missing lot and/or exp date The recall status is terminated (terminated May 7, 2020). Affected quantity: 19,390 syringes.

Recall details

Product Type
Drugs
Report Date
Nov 6, 2019
Initiation Date
Oct 21, 2019
Termination Date
May 7, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
19,390 syringes

Product description

PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL), Rx Only, Single-Dose Container, 5 x 10 mL pre-filled syringes, Nephron 503B Outsourcing Facility 4500 12th St. Ext West Columbia, SC 29172, NDC 69374-919-10.

Reason for recall

Incorrect labeling: Incorrect or missing lot and/or exp date

Distribution pattern

Nationwide in the U.S.

Code information

Lots: SU9079A, SU9079B, Exp 4/5/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0154-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0154-2020. Report a data issue: hello@regdatalab.com.